These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38697358)

  • 21. β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway.
    Chen Y; Ouyang X; Hoque R; Garcia-Martinez I; Yousaf MN; Tonack S; Offermanns S; Dubuquoy L; Louvet A; Mathurin P; Massey V; Schnabl B; Bataller RA; Mehal WZ
    J Hepatol; 2018 Sep; 69(3):687-696. PubMed ID: 29705237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis.
    Takeuchi M; Vidigal PT; Guerra MT; Hundt MA; Robert ME; Olave-Martinez M; Aoki S; Khamphaya T; Kersten R; Kruglov E; de la Rosa Rodriguez R; Banales JM; Nathanson MH; Weerachayaphorn J
    Gut; 2021 Feb; 70(2):342-356. PubMed ID: 33214166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2.
    Lee J; French B; Morgan T; French SW
    Exp Mol Pathol; 2014 Feb; 96(1):118-25. PubMed ID: 24145004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcoholic hepatitis: Prognosis and treatment.
    Casanova J; Bataller R
    Gastroenterol Hepatol; 2014 Apr; 37(4):262-8. PubMed ID: 24656653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ductular Reaction Cells Display an Inflammatory Profile and Recruit Neutrophils in Alcoholic Hepatitis.
    Aguilar-Bravo B; Rodrigo-Torres D; Ariño S; Coll M; Pose E; Blaya D; Graupera I; Perea L; Vallverdú J; Rubio-Tomás T; Dubuquoy L; Armengol C; Lo Nigro A; Stärkel P; Mathurin P; Bataller R; Caballería J; José Lozano J; Ginès P; Sancho-Bru P
    Hepatology; 2019 May; 69(5):2180-2195. PubMed ID: 30565271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1 inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice.
    Iracheta-Vellve A; Petrasek J; Gyogyosi B; Bala S; Csak T; Kodys K; Szabo G
    Liver Int; 2017 Jul; 37(7):968-973. PubMed ID: 28345165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis.
    Poulsen KL; Fan X; Kibler CD; Huang E; Wu X; McMullen MR; Leng L; Bucala R; Ventura-Cots M; Argemi J; Bataller R; Nagy LE
    JCI Insight; 2021 Jun; 6(11):. PubMed ID: 33945507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular targets in the treatment of alcoholic hepatitis.
    Dhanda AD; Lee RW; Collins PL; McCune CA
    World J Gastroenterol; 2012 Oct; 18(39):5504-13. PubMed ID: 23112542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophages and Alcohol-Related Liver Inflammation.
    Ju C; Mandrekar P
    Alcohol Res; 2015; 37(2):251-62. PubMed ID: 26717583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitis.
    Li W; Xia Y; Yang J; Sanyal AJ; Shah VH; Chalasani NP; Yu Q
    medRxiv; 2023 Dec; ():. PubMed ID: 38168393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.
    Colmenero J; Bataller R; Sancho-Bru P; Bellot P; Miquel R; Moreno M; Jares P; Bosch J; Arroyo V; Caballería J; Ginès P
    Gastroenterology; 2007 Feb; 132(2):687-97. PubMed ID: 17258719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo Bruton's tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis.
    Nagesh PT; Cho Y; Zhuang Y; Babuta M; Ortega-Ribera M; Joshi R; Brezani V; Patel A; Datta AA; Brezani V; Hsieh YC; Ramos A; Mehta J; Copeland C; Kanata E; Jiang ZG; Vlachos I; Asara J; ; Szabo G
    Sci Transl Med; 2024 Aug; 16(759):eadg1915. PubMed ID: 39110779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease.
    Sagaram M; Frimodig J; Jayanty D; Hu H; Royer AJ; Bruner R; Kong M; Schwandt ML; Vatsalya V
    Front Immunol; 2023; 14():1202267. PubMed ID: 38162671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mouse model of the regression of alcoholic hepatitis: Monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD
    Kang H; Kim MB; Park YK; Lee JY
    J Nutr Biochem; 2022 Jan; 99():108852. PubMed ID: 34525389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial dysfunction markers predict short-term mortality in patients with severe alcoholic hepatitis.
    Blaya D; Rubio-Tomás T; Rodrigo-Torres D; Lozano J; Coll M; Argemi J; Altamirano J; Affò S; Morales-Ibanez O; Gratacós-Ginès J; Pose E; Tanguy M; Issoufaly T; Rautou PE; Bataller R; Caballería J; Sancho-Bru P
    Hepatol Int; 2021 Aug; 15(4):1006-1017. PubMed ID: 33954832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment.
    Abenavoli L; Masarone M; Federico A; Rosato V; Dallio M; Loguercio C; Persico M
    Rev Recent Clin Trials; 2016; 11(3):159-66. PubMed ID: 27457347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol-induced extracellular ASC specks perpetuate liver inflammation and damage in alcohol-associated hepatitis even after alcohol cessation.
    de Carvalho Ribeiro M; Iracheta-Vellve A; Babuta M; Calenda CD; Copeland C; Zhuang Y; Lowe PP; Hawryluk D; Catalano D; Cho Y; Barton B; Dasarathy S; McClain C; McCullough AJ; Mitchell MC; Nagy LE; Radaeva S; Lien E; Golenbock DT; Szabo G
    Hepatology; 2023 Jul; 78(1):225-242. PubMed ID: 36862512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The non-transcriptional activity of IRF3 modulates hepatic immune cell populations in acute-on-chronic ethanol administration in mice.
    Sanz-Garcia C; Poulsen KL; Bellos D; Wang H; McMullen MR; Li X; Chattopadhyay S; Sen G; Nagy LE
    J Hepatol; 2019 May; 70(5):974-984. PubMed ID: 30710579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcoholic liver disease: A current molecular and clinical perspective.
    Ohashi K; Pimienta M; Seki E
    Liver Res; 2018 Dec; 2(4):161-172. PubMed ID: 31214376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy of acute alcoholic hepatitis in clinical practice.
    Abenavoli L; Milic N; Rouabhia S; Addolorato G
    World J Gastroenterol; 2014 Mar; 20(9):2159-67. PubMed ID: 24605014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.